Antihypertensives Flashcards
Agents along with drugs affecting the Sympathetic Nervous System
Alpha 1 - “-azosin”
B-blockers (NS) - Propranolol, Carvedilol, Pindolol, Timolol
B- blockers (S) - Metoprolol, Atenolol, Bisoprolol, Nebivolol
Agents along with drugs that interfere with the activity of renin- angiotensin
ACE inhibitors - “-pril”
AT1-R blockers - “-sartan”
Renin inhibitor - aliskerin
Calcium Channel Blockers
Phenylalkylamine - Verapamil
Benzothiazepine – Diltiazem
Dihydropyridine – “dipines”
Centrally acting A-2 agonist
Clonidine & Methyldopa
Direct vasodilators
Minoxidil, Nitroprusside, Hydralazine, Fenoldopam
Thiazide diuretics
Chlorothiazide
Renin Angiotensin route
Kidneys release renin.
The liver releases angiotensin pre-cursor.
These two make angiotensin I.
ACE converts angiotensin I -> angiotensin II. Angiotensin II acts on AT1 receptors to cause vasoconstriction & reacts w/ aldosterone to hold on to Na+ & let go of K+.
Vasoconstriction = increase in BP
Hypernatremia = increase in BP because in theory is makes our blood heavier which can cause edema and other stuff
Target of med: Heart
B1B & CCB – decrease cardio output (decrease volume out of the left ventricle = less contraction -> less pressure needed)
Which leads to a decrease in blood pressure because the heart does not have to work as hard
Target of med: kidney
ACEi, ARBs – decrease Na+ and decreases aldosterone
BB – decrease renin/angiotensin II
Diuretics – decrease blood volume/Total peripheral resistance (changes volume of blood with urine = decreased volume -> decreased pressure in vessels to get back to heart less pressure which lowers blood pressure)
Target of med: peripheral vasodilator
Vasodilators, ACEi, CCB – decrease TPR
Target of med: CNS/brain
CA sympathomimetics & BB – decrease TPR
Non med treatment
DASH Diet
Na+(<1500 mg/day) & ETOH (< 2 drinks/day; <1 drinks/day) limitation
Exercise programs
Weight loss for overweight patients
K+ supplementation if indicated (3500-5000 mg/day)
Treatment goals for hypertension
-ACC/AHA - <130/80 mmHg
-SBP of >140mmHg or DBP of >90 mmHg -should be tx w/ one or more medications
-Initial choices for primary HTN:
ACEi, ARBs, CCB, & Thiazide diuretics: (TAAC that Hypertension)
Thiazide diuertics and Thiazide like diuretics drugs
Hydrochlorothiazide (HCTZ), Chlorothiazide, Chlorthalidone, Indapamide.
don’t mind my thiazide (done mide thiazide )
Thiazide diuertics and Thiazide like diuretics drugs Use and MOA
Uses:
HTN – due to Na+ loss via urination & loss of edema (makes blood volume decrease in a sense makes blood light to not as much work to get it back to the heart)
MOA:
Secreted in the proximal tubule and acts in the early distal tubule. They inhibit the electro-neural Na+/Cl- cotransporter
This action increases K+ excretion = K+ sparing diuretics may also be used as well. (like spironolactone)
K+ cause patients to become hypokalemic
Thiazide diuertics and Thiazide like diuretics drugs side effects
Hypokalemia – CI in CHF, Cirrhosis, Diabetic, & Elderly (Hypokalemia S/S:
Cardiac arrhythmias
Muscle cramping/weakness
Lethargy)
Hypercalcemia – because youre holding onto calcium
Hyperglycemia – decrease insulin section
Hyperlipidemia – CI in pts w/ increased cholesterol & lipids
Uric acid reabsorption – CI in gout
ACE-Inhibitor Uses
Inhibits effects of Ang II
Dilates arteries & veins (CHF)
Decreases BP -> may have minor increase in HR (rare)
Baroreceptors are kept intact -> body can still detect changes and will accommodate
Decreases vascular hypertrophy
Increases life-expectancy for CHF pts
Not used in combo w/ Aliskiren or ARBs
Because work in the same system
ACE-Inhibitor Side effects
Hyperkalemia
Dry cough (MC) – Due to degradation of bradykinin which activates stretch receptors in the trachea.
Angioedema - esp. in A.A
Fetotoxicity
ARB’s MOA
Selectively block AT II type I receptors -> No AngII actions
Causes vasodilation & Na+/H20 excretion.
Decreasing TPR, plasma volume, CO, and BP
They don’t affect bradykinin -> no cough = use for when cough is intolerable